---
schema_version: "secwatch.filing_event.v1"
accession: "0001140361-24-009040"
form_type: "8-K"
ticker: "BMY"
cik: "0000014272"
company_name: "BRISTOL MYERS SQUIBB CO"
filed_at: "2024-02-22T23:59:59+00:00"
generated_at: "2026-06-05T18:58:12.416877+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# BMY closes $13.5B multi-tranche note offering to fund Karuna and RayzeBio acquisitions

## Summary
- Issued nine tranches totaling $13.5B: Floating Rate Notes (2026) and fixed-rate notes from 2026 to 2064.
- Proceeds partially fund proposed acquisitions of Karuna Therapeutics and RayzeBio; remainder for general corporate purposes.
- Special mandatory redemption at 101% if Karuna deal not closed by June 30, 2025 or company abandons it (excludes 2034, 2044, 2054, 2064 notes).
- Largest tranches: $2.5B 5.200% notes due 2034 and $2.75B 5.550% notes due 2054.
- Underwriting syndicate includes major banks; customary covenants and events of default apply.

## SEC filing metadata
- accession: 0001140361-24-009040
- form_type: 8-K
- ticker: BMY
- cik: 0000014272
- company_name: BRISTOL MYERS SQUIBB CO
- filed_at: 2024-02-22T23:59:59+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 8.01, 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/14272/000114036124009040/0001140361-24-009040-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/14272/000114036124009040/ef20022028_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001140361-24-009040
- JSON: https://secwatch.observer/filing/0001140361-24-009040.json
- Plain text: https://secwatch.observer/filing/0001140361-24-009040.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.